Drug testing for the 21st century.

Buzzkill Labs is bridging the gap between outdated drug testing choices of yesterday and the growing need for faster, more practical and cost-effective solutions of today. We are automating lab-standard processes in combination with proprietary, high-sensitivity trace detection technology to deliver rapid testing solutions. For cannabis, and beyond.

The leadership team at Buzzkill Labs has a strong track record in developing and successfully commercializing game changing technologies.

George Farquar, CTO
Jeff Heimburger, CEO
Dan Chandler, COO

George is a serial entrepreneur whose innovations have led to the founding of three companies. He won the 2013 R&D 100 award for a biothreat detection technology, still in use by governments and enterprises around the world today. George holds a PhD in Physical Chemistry from LSU and led research teams at Oakridge and Lawrence Livermore National Laboratories for more than a decade before becoming a founder.

For over two decades, Jeff led commercial organizations within market leaders such as Abbott, Roche, Agilent, and Focus Diagnostics, a Quest Diagnostics subsidiary. He also led sales and marketing teams for startups acquired by Thermo Fisher and Danaher in the forensic and diagnostic markets. Jeff has successfully launched dozens of products worldwide for the largest global molecular diagnostics businesses and for upstart innovators. Jeff studied mechanical engineering and biology at Purdue University.


Buzzkill Labs is always looking to partner with new channel partners, confirmation labs, collection facilities, TPAs, and employers seeking to update their drug testing programs. Drop us a line in this form.